The Trulieve Cannabis Corp. (CSE:TRUL) share price has done very well over the last month, posting an excellent gain of 29%. But the gains over the last month weren’t enough to make shareholders whole, as the share price is still down 4.8% in the last twelve months.
In spite of the firm bounce in price, you could still be forgiven for feeling indifferent about Trulieve Cannabis’ P/S ratio of 1.1x, since the median price-to-sales (or “P/S”) ratio for the Pharmaceuticals industry in Canada is also close to 1x. Although, it’s not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.
View our latest analysis for Trulieve Cannabis
How Trulieve Cannabis Has Been Performing
Trulieve Cannabis hasn’t been tracking well recently as its declining revenue compares poorly to other companies, which…
